Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Intimation of Board ....
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mangalam Drugs & Organics Ltd has scheduled a Board of Directors meeting on Thursday, May 14, 2026 at its registered office in Mumbai. The primary agenda is to consider, approve and take on record the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026. In line with SEBI regulations, the Trading Window for directors, officers and designated employees has been closed from April 1, 2026 and will remain closed until 48 hours after the financial results are announced. The filing is made pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015.
Shareholders can expect the Q4 and full-year FY2026 results to be announced around May 14, 2026. The trading window closure indicates no insider trading activities during this quiet period.